Loại tài liệu:    Chỉ tìm trong: 
301-310 trong số 403 kết quả
Iruplinalkib for G1202R-mutant non-small cell lung cancer with anaplastic lymphoma kinase double fusion failed to alectinib: a case report
Tác giả: Guangjian Yang, Jiaqi Hu, Runze Liu, Pei Li, Linke Yang, Xiaoyong Tang, Luokun Wang
Xuất bản: England: Anti-cancer drugs , 2025
Bộ sưu tập: NCBI
ddc: 
 
Efficacy and safety of first-line immunotherapy-based regimens for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis
Tác giả: Wengang Zhang, Wencheng Zhao, Hao Wang, Yayi He, Xinyu Zhang, Zhiyi Guo, Li Ye, Zhimin Chen, Kandi Xu, Lishu Zhao, Xinyue Liu, Yujin Liu
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc: 
 
Lobectomy plus lobe-specific lymphadenectomy as the minimum standards of curative resection for hypermetabolic clinical stage IA non-small cell lung cancer
Tác giả: Runze Li, Zhifei Li, Peng Li, Jianchuan Chen, Bin Qiu, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc: 
 
Video-assisted mediastinocopic lymphadenectomy (VAMLA) for restaging clinical N2-3 non-small cell lung cancer (NSCLC) after neoadjuvant treatment
Tác giả: Nina Reig-Oussedik, Sergi Call, Carme Obiols, Bruno Garcia-Cabo, José Sanz-Santos, Lucía Reyes Cabanillas-Paredes, Juan Manuel Ochoa-Alba, Mireia Serra-Mitjans, Ramón Rami-Porta
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc: 
 
Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
Tác giả: Mylène Wespiser, Aurélie Swalduz, Maurice Pérol
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc: 
 
Transformation from acquired EGFR 19del/C797S to EGFR 19del/T790M in an advanced non-small cell lung cancer patient: a case report and literature review
Tác giả: Xianhuai Jin, Yaping Quan, Jiao Liu, Yong Hu, Hao Li
Xuất bản: England: Anti-cancer drugs , 2025
Bộ sưu tập: NCBI
ddc: 
 
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Tác giả: Guido Ghilardi, Zainul S Hasanali, Sandra P Susanibar-Adaniya, Lena E Winestone, Marco Ruella, Alfred L Garfall
Xuất bản: England: Journal for immunotherapy of cancer , 2025
Bộ sưu tập: NCBI
ddc: 
 
By integrating single-cell RNA sequencing and bulk RNA sequencing, plasma cells signature and tertiary lymphoid structures were verified to contribute to outcome in lung adenocarcinoma
Tác giả: Zetian Gong, Xianchuang Xu, Wei Wang, Yaolin Cao, Yanlong Feng, Jiatao Liu, Jinpeng Yang, Wenyu Wang, Hui Gong, Jun Li, Liang Chen
Xuất bản: China: Translational cancer research , 2025
Bộ sưu tập: NCBI
ddc: 
 
Low-dose anlotinib plus immune checkpoint inhibitors offers better efficacy and safety in advanced non-small cell lung cancer treatment
Tác giả: Tingfei Tan, Siyu Yuan, Weiwei Chu, Jiemei Jiang, Meiling Chen, Quan Xia, Junping Wang
Xuất bản: England: Anti-cancer drugs , 2025
Bộ sưu tập: NCBI
ddc: 
 
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Tác giả: Guido Ghilardi, Zainul S Hasanali, Sandra P Susanibar-Adaniya, Lena E Winestone, Marco Ruella, Alfred L Garfall
Xuất bản: England: Journal for immunotherapy of cancer , 2025
Bộ sưu tập: NCBI
ddc: 
 

Truy cập nhanh danh mục